IL-22 promotes tumorigenic functions, by activating STAT3 phosphorylation and inducing mitogenic and other pro-tumor genes in several tumor lines, including BCC and SCC lines [33, 11]. This evidence concerns the gene IL22 and skin basal cell carcinoma.